 | • レポートコード：MRC2305C226 • 出版社/出版日：360iResearch / 2022年10月 • レポート形態：英語、PDF、220ページ • 納品方法：Eメール（受注後2-3日） • 産業分類：医療 |
| Single User（1名利用、印刷可） | ￥742,350 (USD4,949) | ▷ お問い合わせ |
| Enterprise License（企業利用、印刷可） | ￥1,492,350 (USD9,949) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 360iResearch社は、世界のバイオイメージング市場規模が2021年に178.9億ドル、2022年に188.5億ドルとなり、更に年平均5.57％成長して2027年には247.7億ドルに達すると予測しています。当市場調査レポートでは、バイオイメージングの世界市場を総合的に分析し、序論、調査方法、エグゼクティブサマリー、市場概要、市場インサイト、種類別分析（エラストグラフィー、MRI、医療用超音波検査、X線撮影）、技術別分析（医療技術、分子技術）、用途別分析（クリニック、診断センター、病院、研究室）、地域別分析（南北アメリカ、アメリカ、カナダ、ブラジル、アジア太平洋、日本、中国、インド、韓国、台湾、ヨーロッパ/中東/アフリカ、イギリス、ドイツ、フランス、ロシア、その他）、競争状況、企業情報などの内容を掲載しています。なお、当書には、Bayer HealthCare Pharmaceuticals、Bio-Medical Electronics Co., Ltd.、Bracco Imaging S.P.A、Canon Medical Systems Corporation、Covidien Pharmaceuticals、Digirad Corporation、Fonar Corporation、Gamma Medica Inc、GE Healthcare、Hitachi Medical Corporationなどの企業情報が含まれています。 ・序論 ・調査方法 ・エグゼクティブサマリー ・市場概要 ・市場インサイト ・世界のバイオイメージング市場規模：種類別 - エラストグラフィーの市場規模 - MRIの市場規模 - 医療用超音波検査の市場規模 - X線撮影の市場規模 ・世界のバイオイメージング市場規模：技術別 - 医療技術の市場規模 - 分子技術の市場規模 ・世界のバイオイメージング市場規模：用途別 - クリニックにおける市場規模 - 診断センターにおける市場規模 - 病院における市場規模 - 研究室における市場規模 ・世界のバイオイメージング市場規模：地域別 - 南北アメリカのバイオイメージング市場規模 アメリカのバイオイメージング市場規模 カナダのバイオイメージング市場規模 ブラジルのバイオイメージング市場規模 ... - アジア太平洋のバイオイメージング市場規模 日本のバイオイメージング市場規模 中国のバイオイメージング市場規模 インドのバイオイメージング市場規模 韓国のバイオイメージング市場規模 台湾のバイオイメージング市場規模 ... - ヨーロッパ/中東/アフリカのバイオイメージング市場規模 イギリスのバイオイメージング市場規模 ドイツのバイオイメージング市場規模 フランスのバイオイメージング市場規模 ロシアのバイオイメージング市場規模 ... - その他地域のバイオイメージング市場規模 ・競争状況 ・企業情報 |
The Global Bio-imaging Market size was estimated at USD 17.89 billion in 2021 and expected to reach USD 18.85 billion in 2022, and is projected to grow at a CAGR 5.57% to reach USD 24.77 billion by 2027.
Market Statistics:
The report provides market sizing and forecast across 7 major currencies – USD, EUR, JPY, GBP, AUD, CAD, and CHF. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2018 and 2020 are considered as historical years, 2021 as the base year, 2022 as the estimated year, and years from 2023 to 2027 are considered as the forecast period.
Market Segmentation & Coverage:
This research report categorizes the Bio-imaging to forecast the revenues and analyze the trends in each of the following sub-markets:
Based on Type, the market was studied across Elastography, Magnetic Resonance Imaging, Medical Ultrasonography or Ultrasound, and X-ray Radiography.
Based on Technology, the market was studied across Medical Technology and Molecular Technology. The Medical Technology is further studied across Biomarkers, Molecular Probes, and Nano Bio-Imaging. The Molecular Technology is further studied across Magnetic Resonance Imaging, Optical Imaging, Radiological Imaging, and Ultrasound Imaging.
Based on Application, the market was studied across Clinics, Diagnostic Centers, Hospitals, and Laboratories.
Based on Region, the market was studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.
Cumulative Impact of COVID-19:
COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.
Cumulative Impact of 2022 Russia Ukraine Conflict:
We continuously monitor and update reports on political and economic uncertainty due to the Russian invasion of Ukraine. Negative impacts are significantly foreseen globally, especially across Eastern Europe, European Union, Eastern & Central Asia, and the United States. This contention has severely affected lives and livelihoods and represents far-reaching disruptions in trade dynamics. The potential effects of ongoing war and uncertainty in Eastern Europe are expected to have an adverse impact on the world economy, with especially long-term harsh effects on Russia.This report uncovers the impact of demand & supply, pricing variants, strategic uptake of vendors, and recommendations for Bio-imaging market considering the current update on the conflict and its global response.
Competitive Strategic Window:
The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.
FPNV Positioning Matrix:
The FPNV Positioning Matrix evaluates and categorizes the vendors in the Bio-imaging Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.
Market Share Analysis:
The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.
Competitive Scenario:
The Competitive Scenario provides an outlook analysis of the various business growth strategies adopted by the vendors. The news covered in this section deliver valuable thoughts at the different stage while keeping up-to-date with the business and engage stakeholders in the economic debate. The competitive scenario represents press releases or news of the companies categorized into Merger & Acquisition, Agreement, Collaboration, & Partnership, New Product Launch & Enhancement, Investment & Funding, and Award, Recognition, & Expansion. All the news collected help vendor to understand the gaps in the marketplace and competitor’s strength and weakness thereby, providing insights to enhance product and service.
Company Usability Profiles:
The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Bio-imaging Market, including Bayer HealthCare Pharmaceuticals, Bio-Medical Electronics Co., Ltd., Bracco Imaging S.P.A, Canon Medical Systems Corporation, Covidien Pharmaceuticals, Digirad Corporation, Esaote S.p.A, Fonar Corporation, Gamma Medica Inc, GE Healthcare, Hitachi Medical Corporation, Hologic Inc, Kitware, Inc., Lantheus Medical Imaging, Inc., Mindray Medical International Limited, NANOCO GROUP PLC, OWKIN, INC., Philips Healthcare, Positron Corporation, Samsung Medison Co.Ltd, Shenzhen Mindray, Siemens Healthcare, SonoSite, Inc, The European Molecular Biology Laboratory, and Toshiba Medical Systems.
The report provides insights on the following pointers:
1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments
The report answers questions such as:
1. What is the market size and forecast of the Global Bio-imaging Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Bio-imaging Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Bio-imaging Market?
4. What is the competitive strategic window for opportunities in the Global Bio-imaging Market?
5. What are the technology trends and regulatory frameworks in the Global Bio-imaging Market?
6. What is the market share of the leading vendors in the Global Bio-imaging Market?
7. What modes and strategic moves are considered suitable for entering the Global Bio-imaging Market?
1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Early diagnosis of diseases such as cancer with rise in aging population
5.1.1.2. Increase in number of hospitals and diagnostic centers
5.1.1.3. Adoption of biomedical imaging in food and agriculture sector
5.1.2. Restraints
5.1.2.1. Difficulty in differentiating between benign and aggressive tumors
5.1.3. Opportunities
5.1.3.1. Technological innovations such as pill camera and portable technology
5.1.3.2. Application of IT in healthcare and growth in bioinformatics sector
5.1.4. Challenges
5.1.4.1. Costly bio-imaging equipment
5.2. Cumulative Impact of COVID-19
6. Bio-imaging Market, by Type
6.1. Introduction
6.2. Elastography
6.3. Magnetic Resonance Imaging
6.4. Medical Ultrasonography or Ultrasound
6.5. X-ray Radiography
7. Bio-imaging Market, by Technology
7.1. Introduction
7.2. Medical Technology
7.3.1. Biomarkers
7.3.2. Molecular Probes
7.3.3. Nano Bio-Imaging
7.3. Molecular Technology
7.4.1. Magnetic Resonance Imaging
7.4.2. Optical Imaging
7.4.3. Radiological Imaging
7.4.4. Ultrasound Imaging
8. Bio-imaging Market, by Application
8.1. Introduction
8.2. Clinics
8.3. Diagnostic Centers
8.4. Hospitals
8.5. Laboratories
9. Americas Bio-imaging Market
9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States
10. Asia-Pacific Bio-imaging Market
10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Taiwan
10.12. Thailand
10.13. Vietnam
11. Europe, Middle East & Africa Bio-imaging Market
11.1. Introduction
11.2. Denmark
11.3. Egypt
11.4. Finland
11.5. France
11.6. Germany
11.7. Israel
11.8. Italy
11.9. Netherlands
11.10. Nigeria
11.11. Norway
11.12. Poland
11.13. Qatar
11.14. Russia
11.15. Saudi Arabia
11.16. South Africa
11.17. Spain
11.18. Sweden
11.19. Switzerland
11.20. Turkey
11.21. United Arab Emirates
11.22. United Kingdom
12. Competitive Landscape
12.1. FPNV Positioning Matrix
12.1.1. Quadrants
12.1.2. Business Strategy
12.1.3. Product Satisfaction
12.2. Market Ranking Analysis, By Key Player
12.3. Market Share Analysis, By Key Player
12.4. Competitive Scenario
12.4.1. Merger & Acquisition
12.4.2. Agreement, Collaboration, & Partnership
12.4.3. New Product Launch & Enhancement
12.4.4. Investment & Funding
12.4.5. Award, Recognition, & Expansion
13. Company Usability Profiles
13.1. Bayer HealthCare Pharmaceuticals
13.1.1. Business Overview
13.1.2. Key Executives
13.1.3. Product & Services
13.2. Bio-Medical Electronics Co., Ltd.
13.2.1. Business Overview
13.2.2. Key Executives
13.2.3. Product & Services
13.3. Bracco Imaging S.P.A
13.3.1. Business Overview
13.3.2. Key Executives
13.3.3. Product & Services
13.4. Canon Medical Systems Corporation
13.4.1. Business Overview
13.4.2. Key Executives
13.4.3. Product & Services
13.5. Covidien Pharmaceuticals
13.5.1. Business Overview
13.5.2. Key Executives
13.5.3. Product & Services
13.6. Digirad Corporation
13.6.1. Business Overview
13.6.2. Key Executives
13.6.3. Product & Services
13.7. Esaote S.p.A
13.7.1. Business Overview
13.7.2. Key Executives
13.7.3. Product & Services
13.8. Fonar Corporation
13.8.1. Business Overview
13.8.2. Key Executives
13.8.3. Product & Services
13.9. Gamma Medica Inc
13.9.1. Business Overview
13.9.2. Key Executives
13.9.3. Product & Services
13.10. GE Healthcare
13.10.1. Business Overview
13.10.2. Key Executives
13.10.3. Product & Services
13.11. Hitachi Medical Corporation
13.11.1. Business Overview
13.11.2. Key Executives
13.11.3. Product & Services
13.12. Hologic Inc
13.12.1. Business Overview
13.12.2. Key Executives
13.12.3. Product & Services
13.13. Kitware, Inc.
13.13.1. Business Overview
13.13.2. Key Executives
13.13.3. Product & Services
13.14. Lantheus Medical Imaging, Inc.
13.14.1. Business Overview
13.14.2. Key Executives
13.14.3. Product & Services
13.15. Mindray Medical International Limited
13.15.1. Business Overview
13.15.2. Key Executives
13.15.3. Product & Services
13.16. NANOCO GROUP PLC
13.16.1. Business Overview
13.16.2. Key Executives
13.16.3. Product & Services
13.17. OWKIN, INC.
13.17.1. Business Overview
13.17.2. Key Executives
13.17.3. Product & Services
13.18. Philips Healthcare
13.18.1. Business Overview
13.18.2. Key Executives
13.18.3. Product & Services
13.19. Positron Corporation
13.19.1. Business Overview
13.19.2. Key Executives
13.19.3. Product & Services
13.20. Samsung Medison Co.Ltd
13.20.1. Business Overview
13.20.2. Key Executives
13.20.3. Product & Services
13.21. Shenzhen Mindray
13.21.1. Business Overview
13.21.2. Key Executives
13.21.3. Product & Services
13.22. Siemens Healthcare
13.22.1. Business Overview
13.22.2. Key Executives
13.22.3. Product & Services
13.23. SonoSite, Inc
13.23.1. Business Overview
13.23.2. Key Executives
13.23.3. Product & Services
13.24. The European Molecular Biology Laboratory
13.24.1. Business Overview
13.24.2. Key Executives
13.24.3. Product & Services
13.25. Toshiba Medical Systems
13.25.1. Business Overview
13.25.2. Key Executives
13.25.3. Product & Services
14. Appendix
14.1. Discussion Guide
14.2. License & Pricing